IRIS
GARIPOLI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.625
NA - Nord America 1.453
AS - Asia 465
SA - Sud America 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.451
SE - Svezia 433
IE - Irlanda 376
IT - Italia 345
CN - Cina 264
SG - Singapore 155
UA - Ucraina 97
GB - Regno Unito 89
DE - Germania 81
PL - Polonia 73
FI - Finlandia 48
FR - Francia 28
IN - India 23
BE - Belgio 20
VN - Vietnam 6
ID - Indonesia 5
NL - Olanda 5
SI - Slovenia 5
AT - Austria 4
IR - Iran 4
ES - Italia 3
JP - Giappone 3
PT - Portogallo 3
BR - Brasile 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
LV - Lettonia 2
RO - Romania 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HK - Hong Kong 1
HU - Ungheria 1
KR - Corea 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.555
Salva come PNG Salva come JPEG
Città #
Dublin 376
Chandler 344
Nyköping 218
Jacksonville 208
Singapore 128
Beijing 90
Messina 79
Ann Arbor 72
Warsaw 71
Dearborn 69
Ashburn 66
Princeton 55
Medford 53
Cambridge 47
Des Moines 42
New York 38
Boardman 31
Lancaster 30
Jinan 22
Brussels 20
Woodbridge 20
Rome 18
Pune 17
Shenyang 16
Hebei 13
Los Angeles 13
Wilmington 12
Milan 11
San Mateo 11
Tianjin 11
Haikou 10
Hangzhou 10
Nanchang 10
Zhengzhou 10
Catania 8
Leawood 8
Nanjing 8
Trento 8
Lanzhou 7
Ningbo 7
Augusta 6
Changsha 6
Dong Ket 6
Taizhou 6
Jakarta 5
Murska Sobota 5
Redwood City 5
Edinburgh 4
Helsinki 4
Jiaxing 4
London 4
Paris 4
Vienna 4
Aci Catena 3
Ardabil 3
Carlentini 3
Florence 3
Fuzhou 3
Guangzhou 3
Hefei 3
Hyderabad 3
Rowlett 3
Scandicci 3
Seattle 3
Taiyuan 3
Washington 3
Anguillara Sabazia 2
Bagnara Calabra 2
Bologna 2
Bremen 2
Brooklyn 2
Caltagirone 2
Cermenate 2
Chicago 2
Cimitile 2
Dallas 2
Forestella 2
Genoa 2
Grammichele 2
Gravina di Catania 2
Indore 2
Johannesburg 2
Lamezia Terme 2
Lissone 2
Madrid 2
Monmouth Junction 2
Santa Clara 2
Scarsdale 2
Shanghai 2
Sheffield 2
Siracusa 2
Stockholm 2
Torre del Greco 2
Acireale 1
Amsterdam 1
Athens 1
Atlanta 1
Auckland 1
Bari 1
Belgrade 1
Totale 2.450
Salva come PNG Salva come JPEG
Nome #
RESEZIONE DI METASTASI EPATICHE DA CANCRO DEL COLON DOPO "SHRINKAGE" DI MALATTIA OTTENUTO CON FOLFIRI + CETUXIMAB 189
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 122
Incidence and Outcomes of Bone Metastases. Evaluation of BTAs Therapy, Pain Relief and Quality of Life: Experience from a Single Cancer Center 117
Men with Breast Cancer: 15 Cases 91
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 89
Thyroid gland metastasis from breast cancer as sixth site of disease:A Case Report 89
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen 87
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 83
"Young-old",Old-old", Oldest-old" and breast cancer: Cancer surrender prohibited. Our challenge for 87 patients 81
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 81
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 79
Esperienze cliniche in oncologia:Donna affetta da crcinoma del pancreas con componente neuroendocrina funzionante 79
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. 73
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 73
Sustainability of Eribulin treatment for patients with metastatic breast cancer: is the cost of the drug related to the benefit produced (Effectiveness and Safety)? A single center experience 72
Relapsed or refractory extranodal DLBCL treated with lenalidomide: A single center study 71
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 69
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 69
Combination of Gemcitabine (GEM and Liposomal Pegylate Doxorubicin (PLD) in recurrent/ metastatic breast carcinoma: a phase II study. 68
A randomized factorial trial of sequential doxrubicina and CMF vs CMF and chemoterapy alone vs chemoterapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer 68
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 67
Amifostine in conjuction with G-CSF enhances chemoterapy mobilization of peripheral blood progenitor cell 66
CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA: CORRELATION WITH DISEASE STAGE 65
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 64
Breast. La terapia primaria: stato dell'arte 64
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 64
Endocrine toxicity of immune checkpoint inhibitors (anti-PD-1/PD-L1) in advanced cancer 63
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 62
Il ruolo dell'ormonoterapia nel carcinoma della mammella in eta' geriatrica 61
ZD 1839 IRESSA IN HEAVELY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) ASSESSMENT OF TOLERABILITY AND THE CLINICAL BENEFIT 60
Resistance to PGE(2) inhibition of PWM-stimulated lymphocytes from neoplastic patients 59
L'eritropoietina nel trattamento dell'anemia associata alle sindromi mielodisplastiche 57
Circulating plasma cells in Multiple Myeloma correlation with disease stage 56
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience 55
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study 55
Endoscopic mucosal resection of a large inflammatory fibroid polyp (Vanek's tumor): a case report 54
Impiego della fish nello studio della fusione BCR-ABL in pazienti con leucemia mieloide cronica 54
Terapia con r-IL2 a basse dosi in due pazienti con leucemia mieloide cronica(LMC) in fase blastica 54
null 52
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. 51
Terapia con r-IL-2 a basse dosi in pazienti con mieloma multiplo(MM) sottoposti a terapia con Melphalan a dosi intermedie e reinfusione di cellule staminali periferiche 50
Mobilization of breast cancer cells after priming with cyclophosphamide and G-CSF 50
Preliminary results of a phase II study of amifostine for patients with myelodisplastic syndrome 49
Ruolo della capecitabinanei tumori gastroentericiDalla monoterapia all'associazione nel trattamento della malattia metastatica del colon-retto:ruolo della capecitabina 47
Impact of integrated treatments on patient management in solid tumors: From diagnosis to palliative care. 47
Temozolamide plus oral vinorelbine in the treatment of brain metastases from solid tumours in heavily pre- treated patients. 45
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 45
Southern Bloting:Tecniche ed applicazioni 44
Safety and activity of trastuzumab (TRA) containing therapies as treatment of metastatic breast cancer(MBC): a five year experience. 44
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER 43
Risk of burnout in a sample of oncology healthcare professionals working in a hospital oncology unit with hospice and relationship with dysfunctional metacognitive beliefs 43
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 42
Polycythemia vera and essential thrombocytemia treated with IFN-ALPHA2a: Evidence of a significant clinical activity and molecular response. 41
The interplay between burnout risk and attachment styles among palliative care practitioners 39
null 33
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications 25
Totale 3.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020292 0 0 0 0 0 0 58 60 11 73 65 25
2020/2021567 57 15 126 44 29 56 22 31 38 55 58 36
2021/2022446 3 64 20 15 13 5 24 15 5 101 56 125
2022/20231.241 92 124 56 129 85 117 23 83 470 4 44 14
2023/2024293 20 47 15 27 21 89 10 11 2 13 7 31
2024/2025229 7 14 14 82 60 46 6 0 0 0 0 0
Totale 3.620